Patients with cancer are a vulnerable demographic as they are exposed to a variety of problems during pandemics, including infection susceptibility and disruption of their regular medical care. As a result, healthcare institutions have faced a significant problem in balancing the delivery of continuous cancer care while decreasing the danger of exposure to patients during treatment.
In low and middle-income nations with limited resources, inadequate infrastructure, a paucity of healthcare providers, and a scarcity of medical supplies and personal protective equipment(PPE), the pandemic’s negative impact is likely to disrupt the delivery of critical care.